Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04109118 · ClinicalTrials.gov registry record · Phase 2
Benzodiazepine Discontinuation in Opioid Agonist Therapy
A Phase 2 study, sponsored by Boston Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 4
- Enrollment target
NCT04109118: Completed Phase 2 study, sponsored by Boston Medical Center.
NCT04109118 is a Phase 2 study that has completed, run by Boston Medical Center. The registered enrollment target is 4 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04109118, a Phase 2 study, has completed, sponsored by Boston Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 4 participants
- Enrollment target
Study Summary
The proposed study is a clinical trial, designed to pilot test a Distress Tolerance-Benzodiazepine Discontinuation (DT-BD) intervention for patients on opioid agonist therapy who currently use benzodiazepines. The DT-BD intervention is an adjunctive psychosocial intervention in people seeking to discontinue (BZD) use. The goal of the study is to assess the applicability and feasibility of this intervention through treatment retention and qualitative interviews with four participants who are receiving opioid agonist treatment and who regularly use BZDs.
Primary Outcome
Number of participants who rated the intervention as acceptable, this was assessed by conducting an in-depth exit interview with the participant once they complete the entire 13-week study.
Interventions
- BEHAVIORAL Distress Tolerance - Benzodiazepine Discontinuation (DT-BD)
- DRUG BZD discontinuation protocol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2021-03-18 |
| Est. Completion | 2021-07-08 |
| Phase | Phase 2 |
What the finished NCT04109118 record still lists
NCT04109118 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Distress Tolerance - Benzodiazepine Discontinuation (DT-BD) is the first listed.
NCT04109118 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04109118 about?
NCT04109118 is a clinical study titled "Benzodiazepine Discontinuation in Opioid Agonist Therapy". The proposed study is a clinical trial, designed to pilot test a Distress Tolerance-Benzodiazepine Discontinuation (DT-BD) intervention for patients on opioid agonist therapy who currently use benzodiazepines. The DT-BD intervention is an adjunctive psychosocial intervention in people seeking to dis...
What is the current status of trial NCT04109118?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 4 participants. The study started on 2021-03-18. Estimated completion is 2021-07-08.
What interventions are being tested in trial NCT04109118?
The interventions under investigation include: Distress Tolerance - Benzodiazepine Discontinuation (DT-BD) (BEHAVIORAL), BZD discontinuation protocol (DRUG).
Who is sponsoring clinical trial NCT04109118?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04109118's enrollment target sits among peer trials
4 2001st of 2000 the lowest of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI